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Introduction & Objectives
• Proximal and distal pancreatic tumors have different 
anatomic location (head/tail of pancreas) and molecular 
biology. 
• Patients with distal tumors (body/tail) have been associated 
with delayed diagnosis and poorer survival given the 
anatomic location. 
• Understanding the anatomic and genetic differences in 
survival can add further knowledge on prognostic outcomes 




• In adult patients with pancreatic cancer, how does the 
tumor location at the proximal pancreas compared to the 
distal pancreas affect survival when diagnosed at the same 
stage? 
• Hypothesis
• In adult patients with pancreatic cancer, anatomic tumor 
location would contribute to poorer survival in distal 
tumors compared to head tumors when diagnosed at the 
same stage. 
Methods
• Retrospective medical chart review on Epic patient 
database at Thomas Jefferson University Hospital
• 907 patient screened, 324 reviewed patients with 
pancreatic adenocarcinoma (236 head and 88 body/tail) 
diagnosed from 2011-2017
• Inclusion criteria: 18 years or older, biopsy proven 
adenocarcinoma and a single mass in the pancreas at 
presentation.
Data Analysis
• Data mining and entry was performed using REDcap 
software.
• CDC National Death Index Registry and obituary reports 
were utilized to determine official dates of death.
• Comparison of median survival from onset of diagnosis in 
cancer staging and tumor location
• Comparative statistics when corrected for stage and 




• The overall body/tail cancer survival was significantly less than pancreatic 
head cancer (11.2 months body/tail compared to 16 months head, 
p=0.015).
• When broken down by stage at diagnosis, the survival for body/tail cases 
was not statistically significant to pancreatic head cases (Stage I/II, 
head=21 months, body/tail=25.7 months, p=0.436; Stage III, head=11.7 
months, body/tail=18.0 months, p=0.393; Stage IV, head=6.5 months, 
body/tail=4.9 months, p=0.675).
• When broken down by surgery, the survival for body/tail cases was not 
statistically significant in comparison to pancreatic head cases (surgery, 
head=24.6 months, body/tail=19.4 months, p=0.795; no surgery, head=8.5 
months, body/tail=5.5 months, p=0.349).
• After adjusting for both stage and surgery, the hazard ratio of body/tail 
reduced from 1.42 to 0.96.
Conclusions
• When stratified by stage there was no statistically significant 
difference in median survival between the proximal or distal 
groups.
• When stratified by surgical resection there was also no 
statistically significant difference in median survival between 
the proximal or distal groups.
• In the early-stage distal pancreatic adenocarcinoma group 
there was a trend towards improved survival of distal over the 
proximal group, though this was not statistically significant. 
However, low overall numbers of distal pancreatic cancer 
cases may have contributed to the non-statistically significant 
value.
Future Directions
• Given the trend towards higher median survival in the 
early-stage distal group, we plan to acquire data from 
2017 to present to increase the number of distal tumors in 
the study population.
• We plan to perform a retrospective review 
Next-Generation Sequencing on tumor tissues to assess for 
differences in molecular characteristics between proximal 
versus distal tumors.
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